Building · Est. 2026

A foundry for the next generation of cell therapies.

Cellfoundry Bio is building the non‑viral, microfluidic engine to democratize access to advanced immunotherapies.

Scientist‑founders, building quietly.

Uday Chintapula, PhD, MRSC
Founder · formerly UPenn
Jina Ko, PhD
Scientific Co‑Founder · Faculty, Penn Medicine & Bioengineering
Scientific Advisory Board
Clinical · Engineering · Manufacturing
  • Xu Xiaowei, MD, PhD
    Penn Medicine · Translational & Clinical Research
  • Sagar Yadavali, PhD
    CEO, Infinifluidics · Microfluidic chip manufacturing
  • Serkan Yaman, PhD
    GMP cell therapy clinical development

Semiconductor foundries transformed computing by making fabrication shared infrastructure. Cellfoundry is applying the same idea to cell therapy — so the next generation of medicines can be built at the speed of care.

Incorporated
2026 · Delaware
Operations
BioLabs Pegasus Park, Dallas
Headquarters
Dallas, Texas

Talk to us.

General & Investors

uday@cellfoundrybio.com

Partnerships, press, and institutional inquiries.

Careers

info@cellfoundrybio.com

We're assembling a founding team of engineers, biologists, and operators. Open spec — send us what you do best.